Kristin Stephens

Companies

• Syros Pharmaceuticals, Inc.Chief Development Officer Jun 10, 2021 to Nov 20, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SPSyros Pharmaceuticals, Inc.0 shares²Nov 18, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 18, 2024Sold 36,133 shares at $0.22 of Syros Pharmaceuticals, Inc.²
• Oct 31, 2024Shares withheld for tax 6,104 shares at $2.09 of Syros Pharmaceuticals, Inc.³
• Oct 31, 2024Exercised options 17,000 shares of Syros Pharmaceuticals, Inc.³
• Apr 1, 2024Shares withheld for tax 4,218 shares at $5.12 of Syros Pharmaceuticals, Inc.⁴
• Mar 31, 2024Exercised options 11,666 shares of Syros Pharmaceuticals, Inc.⁴
• Mar 31, 2024Exercised options 2,000 shares of Syros Pharmaceuticals, Inc.⁴
• Nov 1, 2023Shares withheld for tax 5,676 shares at $2.22 of Syros Pharmaceuticals, Inc.⁵
• Oct 31, 2023Exercised options 17,000 shares of Syros Pharmaceuticals, Inc.⁵
• Apr 3, 2023Shares withheld for tax 623 shares at $2.58 of Syros Pharmaceuticals, Inc.⁶
• Mar 31, 2023Exercised options 2,000 shares of Syros Pharmaceuticals, Inc.⁶
• Apr 1, 2022Shares withheld for tax 14,115 shares at $1.12 of Syros Pharmaceuticals, Inc.⁷